Lumexa Imaging (LMRI) and its subsidiary Lumexa Imaging Outpatient have entered into an amended credit agreement that includes an approximately $823 million secured term loan and a $250 million secured revolving credit facility, according to a regulatory filing Tuesday.
Both facilities will bear interest at either SOFR plus 2.50% or the prime rate plus 1.50%, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.